+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Meningococcal Vaccines Market Intelligence Report - Global Forecast 2023-2030

  • PDF Icon

    Report

  • 192 Pages
  • January 2023
  • Region: Global
  • Think Market Intelligence
  • ID: 5670087
UP TO OFF until Mar 31st 2023
The Global Meningococcal Vaccines Market is projected to reach USD 10,972.72 million by 2030 from USD 5,027.78 million in 2022, at a CAGR 10.24% during the forecast period.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make better decisions.

In this report, the years 2018 and 2021 are considered as historical years, 2022 as the base year, 2023 as the estimated year, and years from 2024 to 2030 are considered as the forecast period.

  • The Americas Meningococcal Vaccines Market size was estimated at USD 1,646.24 million in 2022 and expected to reach USD 1,789.46 million in 2023, at a CAGR 10.30% to reach USD 3,607.83 million by 2030.
  • The Asia-Pacific Meningococcal Vaccines Market size was estimated at USD 1,471.37 million in 2022 and expected to reach USD 1,594.55 million in 2023, at a CAGR 10.22% to reach USD 3,205.13 million by 2030.
  • The Europe, Middle East & Africa Meningococcal Vaccines Market size was estimated at USD 1,910.15 million in 2022 and expected to reach USD 2,069.76 million in 2023, at a CAGR 10.21% to reach USD 4,159.75 million by 2030.

Market Segmentation & Coverage:

The report on the Global Meningococcal Vaccines Market identifies key attributes about the customer to define the potential market and identify different needs across the industry. Understanding the potential customer group's economies and geographies can help gain business acumen for better strategic decision-making. The market coverage across different industry verticals reveals the hidden truth about the players' strategies in different verticals and helps the organization decide target audience. This report gives you the composite view of sub-markets coupled with comprehensive industry coverage and provides you with the right way of accounting factors such as norms & regulations, culture, to make right coverage strategy for the market plan.

This research report categorizes the Global Meningococcal Vaccines Market in order to forecast the revenues and analyze the trends in each of the following sub-markets:

Type:

  • Combination Vaccines
    • MenHibrix
    • Menitorix
  • Conjugate Vaccines
    • Menactra
    • MenAfriVac
    • Meningitec
    • Menjugate
    • Menveo
    • NeisVac-C
    • Nimenrix
    • NmVac4-DT
  • Men B Vaccines
    • Bexsero
    • Trumenba
  • Polysaccharide Vaccines
    • Mencevax
    • Menomune
    • NmVac4

Category:

  • Intramuscular
  • Subcutaneous

Dosage Type:

  • Booster Vaccination
  • Primary Vaccination

End User:

  • Hospital Pharmacies
  • Pediatric Clinic
  • Retail Pharmacies

Target Group:

  • Adult
  • Preteen
  • Teenager

Region:

  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Connecticut
      • Florida
      • Illinois
      • Maryland
      • Minnesota
      • New Jersey
      • New York
      • Ohio
      • Pennsylvania
      • Texas
      • Washington
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom

Company Usability Profiles:

  • Astellas Pharma Inc.
  • AstraZeneca PLC
  • Bio-Manguinhos
  • Bio-Med (P) Limited
  • CanSino Biologics Inc.
  • Chongqing Zhifei Biological Products Co., Ltd.
  • GlaxoSmithKline PLC
  • Incepta Pharmaceuticals Ltd.
  • Merck & Co., Inc.
  • Mitsubishi Tanabe Pharma Corporation
  • Nanolek, LLC
  • Novartis AG
  • Petrovax Pharm
  • Pfizer Inc.
  • Sanofi S.A.
  • Serum Institute of India Pvt. Ltd.
  • Taj Pharmaceuticals Limited
  • Walvax Biotechnology Co., Ltd.
Frequently Asked Questions about the Global Meningococcal Vaccines Market

What is the estimated value of the Global Meningococcal Vaccines Market?

The Global Meningococcal Vaccines Market was estimated to be valued at $5027.78 Million in 2022.

What is the growth rate of the Global Meningococcal Vaccines Market?

The growth rate of the Global Meningococcal Vaccines Market is 10.2%, with an estimated value of $10972.72 Million by 2030.

What is the forecasted size of the Global Meningococcal Vaccines Market?

The Global Meningococcal Vaccines Market is estimated to be worth $10972.72 Million by 2030.

Who are the key companies in the Global Meningococcal Vaccines Market?

Key companies in the Global Meningococcal Vaccines Market include Astellas Pharma Inc., AstraZeneca PLC, Bio, Manguinhos, Bio, Med (P) Limited, CanSino Biologics Inc., Chongqing Zhifei Biological Products Co., Ltd. and Incepta Pharmaceuticals Ltd..

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Market Overview

4. Americas Meningococcal Vaccines Market
4.1. Introduction
4.2. Argentina
4.3. Brazil
4.4. Canada
4.5. Mexico
4.6. United States

5. Asia-Pacific Meningococcal Vaccines Market
5.1. Introduction
5.2. Australia
5.3. China
5.4. India
5.5. Indonesia
5.6. Japan
5.7. Malaysia
5.8. Philippines
5.9. Singapore
5.10. South Korea
5.11. Taiwan
5.12. Thailand
5.13. Vietnam

6. Europe, Middle East & Africa Meningococcal Vaccines Market
6.1. Introduction
6.2. Denmark
6.3. Egypt
6.4. Finland
6.5. France
6.6. Germany
6.7. Israel
6.8. Italy
6.9. Netherlands
6.10. Nigeria
6.11. Norway
6.12. Poland
6.13. Qatar
6.14. Russia
6.15. Saudi Arabia
6.16. South Africa
6.17. Spain
6.18. Sweden
6.19. Switzerland
6.20. Turkey
6.21. United Arab Emirates
6.22. United Kingdom

7. Competitive Landscape
7.1. FPNV Positioning Matrix
7.1.1. Quadrants
7.1.2. Business Strategy
7.1.3. Product Satisfaction
7.2. Market Ranking Analysis, By Key Player
7.3. Market Share Analysis, By Key Player
7.4. Product Portfolio Analysis, By Key Player
7.5. Competitive Scenario
7.5.1. Merger & Acquisition
7.5.2. Agreement, Collaboration, & Partnership
7.5.3. New Product Launch & Enhancement
7.5.4. Investment & Funding
7.5.5. Award, Recognition, & Expansion

8. Company Usability Profiles
8.1. Astellas Pharma Inc.
8.2. AstraZeneca PLC
8.3. Bio-Manguinhos
8.4. Bio-Med (P) Limited
8.5. CanSino Biologics Inc.
8.6. Chongqing Zhifei Biological Products Co., Ltd.
8.7. GlaxoSmithKline PLC
8.8. Incepta Pharmaceuticals Ltd.
8.9. Merck & Co., Inc.
8.10. Mitsubishi Tanabe Pharma Corporation
8.11. Nanolek, LLC
8.12. Novartis AG
8.13. Petrovax Pharm
8.14. Pfizer Inc.
8.15. Sanofi S.A.
8.16. Serum Institute of India Pvt. Ltd.
8.17. Taj Pharmaceuticals Limited
8.18. Walvax Biotechnology Co., Ltd.

9. Appendix
9.1. Discussion Guide
9.2. License & Pricing


List of Figures
FIGURE 1. GLOBAL MENINGOCOCCAL VACCINES MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY REGION, 2022 VS 2030 (%)
FIGURE 4. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL MENINGOCOCCAL VACCINES MARKET COMPETITIVE STRATEGIC WINDOW, BY REGION, 2030
FIGURE 6. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 7. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL MENINGOCOCCAL VACCINES MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
FIGURE 9. AMERICAS MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 10. AMERICAS MENINGOCOCCAL VACCINES MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 11. AMERICAS MENINGOCOCCAL VACCINES MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 12. AMERICAS MENINGOCOCCAL VACCINES MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
FIGURE 13. ARGENTINA MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 14. BRAZIL MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 15. CANADA MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 16. MEXICO MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 17. UNITED STATES MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 18. UNITED STATES MENINGOCOCCAL VACCINES MARKET SIZE, BY STATE, 2022 VS 2030 (%)
FIGURE 19. UNITED STATES MENINGOCOCCAL VACCINES MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 20. UNITED STATES MENINGOCOCCAL VACCINES MARKET COMPETITIVE STRATEGIC WINDOW, BY STATE, 2030
FIGURE 21. ASIA-PACIFIC MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 22. ASIA-PACIFIC MENINGOCOCCAL VACCINES MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 23. ASIA-PACIFIC MENINGOCOCCAL VACCINES MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 24. ASIA-PACIFIC MENINGOCOCCAL VACCINES MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
FIGURE 25. AUSTRALIA MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 26. CHINA MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 27. INDIA MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 28. INDONESIA MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 29. JAPAN MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 30. MALAYSIA MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 31. PHILIPPINES MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 32. SINGAPORE MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 33. SOUTH KOREA MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 34. TAIWAN MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 35. THAILAND MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 36. VIETNAM MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 37. EUROPE, MIDDLE EAST & AFRICA MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 38. EUROPE, MIDDLE EAST & AFRICA MENINGOCOCCAL VACCINES MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 39. EUROPE, MIDDLE EAST & AFRICA MENINGOCOCCAL VACCINES MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 40. EUROPE, MIDDLE EAST & AFRICA MENINGOCOCCAL VACCINES MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
FIGURE 41. DENMARK MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 42. EGYPT MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 43. FINLAND MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 44. FRANCE MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 45. GERMANY MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 46. ISRAEL MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 47. ITALY MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 48. NETHERLANDS MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 49. NIGERIA MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 50. NORWAY MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 51. POLAND MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 52. QATAR MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 53. RUSSIA MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 54. SAUDI ARABIA MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 55. SOUTH AFRICA MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 56. SPAIN MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 57. SWEDEN MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 58. SWITZERLAND MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 59. TURKEY MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 60. UNITED ARAB EMIRATES MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 61. UNITED KINGDOM MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 62. GLOBAL MENINGOCOCCAL VACCINES MARKET: FPNV POSITIONING MATRIX, 2022
FIGURE 63. GLOBAL MENINGOCOCCAL VACCINES MARKET SHARE, BY KEY PLAYER, 2022
FIGURE 64. GLOBAL MENINGOCOCCAL VACCINES MARKET COMPETITIVE SCENARIO, BY KEY TYPE, 2022


List of Tables
TABLE 1. GLOBAL MENINGOCOCCAL VACCINES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
TABLE 3. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL MENINGOCOCCAL VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. AMERICAS MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 7. AMERICAS MENINGOCOCCAL VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 8. AMERICAS MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 9. AMERICAS MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 10. AMERICAS MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
TABLE 11. AMERICAS MENINGOCOCCAL VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 12. AMERICAS MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2018-2030 (USD MILLION)
TABLE 13. ARGENTINA MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 14. ARGENTINA MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 15. ARGENTINA MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 16. ARGENTINA MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
TABLE 17. ARGENTINA MENINGOCOCCAL VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 18. ARGENTINA MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2018-2030 (USD MILLION)
TABLE 19. BRAZIL MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 20. BRAZIL MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 21. BRAZIL MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 22. BRAZIL MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
TABLE 23. BRAZIL MENINGOCOCCAL VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 24. BRAZIL MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2018-2030 (USD MILLION)
TABLE 25. CANADA MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 26. CANADA MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 27. CANADA MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 28. CANADA MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
TABLE 29. CANADA MENINGOCOCCAL VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 30. CANADA MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2018-2030 (USD MILLION)
TABLE 31. MEXICO MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 32. MEXICO MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 33. MEXICO MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 34. MEXICO MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
TABLE 35. MEXICO MENINGOCOCCAL VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 36. MEXICO MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2018-2030 (USD MILLION)
TABLE 37. UNITED STATES MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 38. UNITED STATES MENINGOCOCCAL VACCINES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 39. UNITED STATES MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 40. UNITED STATES MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 41. UNITED STATES MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
TABLE 42. UNITED STATES MENINGOCOCCAL VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 43. UNITED STATES MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2018-2030 (USD MILLION)
TABLE 44. ASIA-PACIFIC MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 45. ASIA-PACIFIC MENINGOCOCCAL VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 46. ASIA-PACIFIC MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 47. ASIA-PACIFIC MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 48. ASIA-PACIFIC MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
TABLE 49. ASIA-PACIFIC MENINGOCOCCAL VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 50. ASIA-PACIFIC MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2018-2030 (USD MILLION)
TABLE 51. AUSTRALIA MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 52. AUSTRALIA MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 53. AUSTRALIA MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 54. AUSTRALIA MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
TABLE 55. AUSTRALIA MENINGOCOCCAL VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 56. AUSTRALIA MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2018-2030 (USD MILLION)
TABLE 57. CHINA MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 58. CHINA MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 59. CHINA MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 60. CHINA MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
TABLE 61. CHINA MENINGOCOCCAL VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 62. CHINA MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2018-2030 (USD MILLION)
TABLE 63. INDIA MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 64. INDIA MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 65. INDIA MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 66. INDIA MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
TABLE 67. INDIA MENINGOCOCCAL VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 68. INDIA MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2018-2030 (USD MILLION)
TABLE 69. INDONESIA MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 70. INDONESIA MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 71. INDONESIA MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 72. INDONESIA MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
TABLE 73. INDONESIA MENINGOCOCCAL VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 74. INDONESIA MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2018-2030 (USD MILLION)
TABLE 75. JAPAN MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 76. JAPAN MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 77. JAPAN MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 78. JAPAN MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
TABLE 79. JAPAN MENINGOCOCCAL VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 80. JAPAN MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2018-2030 (USD MILLION)
TABLE 81. MALAYSIA MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 82. MALAYSIA MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 83. MALAYSIA MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 84. MALAYSIA MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
TABLE 85. MALAYSIA MENINGOCOCCAL VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 86. MALAYSIA MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2018-2030 (USD MILLION)
TABLE 87. PHILIPPINES MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 88. PHILIPPINES MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 89. PHILIPPINES MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 90. PHILIPPINES MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
TABLE 91. PHILIPPINES MENINGOCOCCAL VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 92. PHILIPPINES MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2018-2030 (USD MILLION)
TABLE 93. SINGAPORE MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 94. SINGAPORE MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 95. SINGAPORE MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 96. SINGAPORE MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
TABLE 97. SINGAPORE MENINGOCOCCAL VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 98. SINGAPORE MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2018-2030 (USD MILLION)
TABLE 99. SOUTH KOREA MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 100. SOUTH KOREA MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 101. SOUTH KOREA MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 102. SOUTH KOREA MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
TABLE 103. SOUTH KOREA MENINGOCOCCAL VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 104. SOUTH KOREA MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2018-2030 (USD MILLION)
TABLE 105. TAIWAN MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 106. TAIWAN MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 107. TAIWAN MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 108. TAIWAN MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
TABLE 109. TAIWAN MENINGOCOCCAL VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 110. TAIWAN MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2018-2030 (USD MILLION)
TABLE 111. THAILAND MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 112. THAILAND MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 113. THAILAND MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 114. THAILAND MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
TABLE 115. THAILAND MENINGOCOCCAL VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 116. THAILAND MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2018-2030 (USD MILLION)
TABLE 117. VIETNAM MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 118. VIETNAM MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 119. VIETNAM MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 120. VIETNAM MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
TABLE 121. VIETNAM MENINGOCOCCAL VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 122. VIETNAM MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2018-2030 (USD MILLION)
TABLE 123. EUROPE, MIDDLE EAST & AFRICA MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 124. EUROPE, MIDDLE EAST & AFRICA MENINGOCOCCAL VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 125. EUROPE, MIDDLE EAST & AFRICA MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 126. EUROPE, MIDDLE EAST & AFRICA MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
TABLE 128. EUROPE, MIDDLE EAST & AFRICA MENINGOCOCCAL VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 129. EUROPE, MIDDLE EAST & AFRICA MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2018-2030 (USD MILLION)
TABLE 130. DENMARK MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 131. DENMARK MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 132. DENMARK MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 133. DENMARK MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
TABLE 134. DENMARK MENINGOCOCCAL VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 135. DENMARK MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2018-2030 (USD MILLION)
TABLE 136. EGYPT MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 137. EGYPT MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 138. EGYPT MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 139. EGYPT MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
TABLE 140. EGYPT MENINGOCOCCAL VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 141. EGYPT MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2018-2030 (USD MILLION)
TABLE 142. FINLAND MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 143. FINLAND MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 144. FINLAND MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 145. FINLAND MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
TABLE 146. FINLAND MENINGOCOCCAL VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 147. FINLAND MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2018-2030 (USD MILLION)
TABLE 148. FRANCE MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 149. FRANCE MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 150. FRANCE MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 151. FRANCE MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
TABLE 152. FRANCE MENINGOCOCCAL VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 153. FRANCE MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2018-2030 (USD MILLION)
TABLE 154. GERMANY MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 155. GERMANY MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 156. GERMANY MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 157. GERMANY MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
TABLE 158. GERMANY MENINGOCOCCAL VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 159. GERMANY MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2018-2030 (USD MILLION)
TABLE 160. ISRAEL MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 161. ISRAEL MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 162. ISRAEL MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 163. ISRAEL MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
TABLE 164. ISRAEL MENINGOCOCCAL VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 165. ISRAEL MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2018-2030 (USD MILLION)
TABLE 166. ITALY MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 167. ITALY MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 168. ITALY MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 169. ITALY MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
TABLE 170. ITALY MENINGOCOCCAL VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 171. ITALY MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2018-2030 (USD MILLION)
TABLE 172. NETHERLANDS MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 173. NETHERLANDS MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 174. NETHERLANDS MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 175. NETHERLANDS MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
TABLE 176. NETHERLANDS MENINGOCOCCAL VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 177. NETHERLANDS MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2018-2030 (USD MILLION)
TABLE 178. NIGERIA MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 179. NIGERIA MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 180. NIGERIA MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 181. NIGERIA MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
TABLE 182. NIGERIA MENINGOCOCCAL VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 183. NIGERIA MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2018-2030 (USD MILLION)
TABLE 184. NORWAY MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 185. NORWAY MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 186. NORWAY MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 187. NORWAY MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
TABLE 188. NORWAY MENINGOCOCCAL VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 189. NORWAY MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2018-2030 (USD MILLION)
TABLE 190. POLAND MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 191. POLAND MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 192. POLAND MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 193. POLAND MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
TABLE 194. POLAND MENINGOCOCCAL VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 195. POLAND MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2018-2030 (USD MILLION)
TABLE 196. QATAR MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 197. QATAR MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 198. QATAR MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 199. QATAR MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
TABLE 200. QATAR MENINGOCOCCAL VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 201. QATAR MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2018-2030 (USD MILLION)
TABLE 202. RUSSIA MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 203. RUSSIA MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 204. RUSSIA MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 205. RUSSIA MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
TABLE 206. RUSSIA MENINGOCOCCAL VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 207. RUSSIA MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2018-2030 (USD MILLION)
TABLE 208. SAUDI ARABIA MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 209. SAUDI ARABIA MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 210. SAUDI ARABIA MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 211. SAUDI ARABIA MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
TABLE 212. SAUDI ARABIA MENINGOCOCCAL VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 213. SAUDI ARABIA MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2018-2030 (USD MILLION)
TABLE 214. SOUTH AFRICA MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 215. SOUTH AFRICA MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 216. SOUTH AFRICA MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 217. SOUTH AFRICA MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
TABLE 218. SOUTH AFRICA MENINGOCOCCAL VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 219. SOUTH AFRICA MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2018-2030 (USD MILLION)
TABLE 220. SPAIN MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 221. SPAIN MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 222. SPAIN MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 223. SPAIN MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
TABLE 224. SPAIN MENINGOCOCCAL VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 225. SPAIN MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2018-2030 (USD MILLION)
TABLE 226. SWEDEN MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 227. SWEDEN MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 228. SWEDEN MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 229. SWEDEN MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
TABLE 230. SWEDEN MENINGOCOCCAL VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 231. SWEDEN MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2018-2030 (USD MILLION)
TABLE 232. SWITZERLAND MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 233. SWITZERLAND MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 234. SWITZERLAND MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 235. SWITZERLAND MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
TABLE 236. SWITZERLAND MENINGOCOCCAL VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 237. SWITZERLAND MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2018-2030 (USD MILLION)
TABLE 238. TURKEY MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 239. TURKEY MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 240. TURKEY MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 241. TURKEY MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
TABLE 242. TURKEY MENINGOCOCCAL VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 243. TURKEY MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2018-2030 (USD MILLION)
TABLE 244. UNITED ARAB EMIRATES MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 245. UNITED ARAB EMIRATES MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 246. UNITED ARAB EMIRATES MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 247. UNITED ARAB EMIRATES MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
TABLE 248. UNITED ARAB EMIRATES MENINGOCOCCAL VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 249. UNITED ARAB EMIRATES MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2018-2030 (USD MILLION)
TABLE 250. UNITED KINGDOM MENINGOCOCCAL VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 251. UNITED KINGDOM MENINGOCOCCAL VACCINES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 252. UNITED KINGDOM MENINGOCOCCAL VACCINES MARKET SIZE, BY CATEGORY, 2018-2030 (USD MILLION)
TABLE 253. UNITED KINGDOM MENINGOCOCCAL VACCINES MARKET SIZE, BY DOSAGE TYPE, 2018-2030 (USD MILLION)
TABLE 254. UNITED KINGDOM MENINGOCOCCAL VACCINES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 255. UNITED KINGDOM MENINGOCOCCAL VACCINES MARKET SIZE, BY TARGET GROUP, 2018-2030 (USD MILLION)
TABLE 256. GLOBAL MENINGOCOCCAL VACCINES MARKET: FPNV POSITIONING MATRIX - SCORES, 2022
TABLE 257. GLOBAL MENINGOCOCCAL VACCINES MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2022
TABLE 258. GLOBAL MENINGOCOCCAL VACCINES MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2022
TABLE 259. GLOBAL MENINGOCOCCAL VACCINES MARKET RANKING, BY KEY PLAYER, 2022
TABLE 260. GLOBAL MENINGOCOCCAL VACCINES MARKET SHARE, BY KEY PLAYER, 2022
TABLE 261. GLOBAL MENINGOCOCCAL VACCINES MARKET PRODUCT PORTFOLIO ANALYSIS, BY KEY PLAYER, 2022
TABLE 262. GLOBAL MENINGOCOCCAL VACCINES MARKET MERGER & ACQUISITION
TABLE 263. GLOBAL MENINGOCOCCAL VACCINES MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 264. GLOBAL MENINGOCOCCAL VACCINES MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 265. GLOBAL MENINGOCOCCAL VACCINES MARKET INVESTMENT & FUNDING
TABLE 266. GLOBAL MENINGOCOCCAL VACCINES MARKET AWARD, RECOGNITION, & EXPANSION
TABLE 267. GLOBAL MENINGOCOCCAL VACCINES MARKET: LICENSE & PRICING

Companies Mentioned

  • Astellas Pharma Inc.
  • AstraZeneca PLC
  • Bio-Manguinhos
  • Bio-Med (P) Limited
  • CanSino Biologics Inc.
  • Chongqing Zhifei Biological Products Co., Ltd.
  • GlaxoSmithKline PLC
  • Incepta Pharmaceuticals Ltd.
  • Merck & Co., Inc.
  • Mitsubishi Tanabe Pharma Corporation
  • Nanolek, LLC
  • Novartis AG
  • Petrovax Pharm
  • Pfizer Inc.
  • Sanofi S.A.
  • Serum Institute of India Pvt. Ltd.
  • Taj Pharmaceuticals Limited
  • Walvax Biotechnology Co., Ltd.

Methodology

Loading
LOADING...